<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17905</article-id><article-id pub-id-type="doi">10.15789/2220-7619-CAB-17905</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Comparatively assessed biological models for determining the pathogenic properties of certain pathogens causing community-acquired pneumonia</article-title><trans-title-group xml:lang="ru"><trans-title>Сравнительная оценка разных биологических моделей для определения патогенных свойств некоторых возбудителей внебольничных пневмоний</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="spin">6408-6399</contrib-id><name-alternatives><name xml:lang="en"><surname>Anisimova</surname><given-names>Anastasiya S.</given-names></name><name xml:lang="ru"><surname>Анисимова</surname><given-names>Анастасия Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher, Laboratory of Natural Focal and Zoonotic Infections</p></bio><bio xml:lang="ru"><p>младший научный сотрудник лаборатории природно-очаговых и зоонозных инфекций</p></bio><email>anisimova_as@antiplague.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7772-9276</contrib-id><contrib-id contrib-id-type="spin">6471-8064</contrib-id><name-alternatives><name xml:lang="en"><surname>Aronova</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Аронова</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Leading Researcher, Laboratory of Natural Focal and Zoonotic Infections</p></bio><bio xml:lang="ru"><p>к.б.н., ведущий научный сотрудник лаборатории природно-очаговых и зоонозных инфекций</p></bio><email>aronova_nv@antiplague.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">9618-4261</contrib-id><name-alternatives><name xml:lang="en"><surname>Tsimbalistova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Цимбалистова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Senior Researcher, Laboratory of Natural Focal and Zoonotic Infections</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, старший научный сотрудник лаборатории природно-очаговых и зоонозных инфекций</p></bio><email>tsimbalistova_mv@antiplague.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">2317-9985</contrib-id><name-alternatives><name xml:lang="en"><surname>Pavlovich</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Павлович</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Head Researcher, Acting Head of the Department of Natural Focal and Zoonotic Infections</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, главный научный сотрудник, и.о. начальника отдела природно-очаговых и зоонозных инфекций</p></bio><email>pavlovich_nv@antiplague.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Levchenko</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Левченко</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Head of the Nursery (Vivarium)</p></bio><bio xml:lang="ru"><p>зав. питомником (виварием)</p></bio><email>levchenko_as@antiplague.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Rostov-on-Don Anti-Plague Institute of Rospotrebnadzor</institution></aff><aff><institution xml:lang="ru">ФКУЗ Ростовский-на-Дону противочумный институт Роспотребнадзора</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-07-02" publication-format="electronic"><day>02</day><month>07</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-12-08" publication-format="electronic"><day>08</day><month>12</month><year>2025</year></pub-date><volume>15</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>881</fpage><lpage>887</lpage><history><date date-type="received" iso-8601-date="2025-03-28"><day>28</day><month>03</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-06-30"><day>30</day><month>06</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Anisimova A.S., Aronova N.V., Tsimbalistova M.V., Pavlovich N.V., Levchenko A.S.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Анисимова А.С., Аронова Н.В., Цимбалистова М.В., Павлович Н.В., Левченко А.С.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Anisimova A.S., Aronova N.V., Tsimbalistova M.V., Pavlovich N.V., Levchenko A.S.</copyright-holder><copyright-holder xml:lang="ru">Анисимова А.С., Аронова Н.В., Цимбалистова М.В., Павлович Н.В., Левченко А.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/17905">https://iimmun.ru/iimm/article/view/17905</self-uri><abstract xml:lang="en"><p>In recent years, it has been of interest to search for alternative, so-called surrogate models to investigate bacterial pathogenicity. The current work was aimed at comparing two biological models (using white mice and <italic>Galleria</italic><italic> </italic><italic>mellonella</italic> larvae) to evaluate the pathogenic potential of community-acquired pneumonia agents. All the studied strains were isolated from the sputum of patients at the Rostov-on-Don Anti-Plague Institute of Rospotrebnadzor and identified by time-of-flight mass spectrometry. The virulence of the pathogen strains was evaluated when white mice and<italic> </italic><italic>G</italic><italic>. </italic><italic>mellonella</italic> larvae were experimentally infected by microbes at various doses (CFU/ml). It was found that the hypermucoid variant of <italic>Klebsiella</italic><italic> </italic><italic>pneumoniae</italic> caused death of white mice at a dose of &lt; 10<sup>3</sup> CFU/mouse, whereas the classical morphotype was apathogenic even at a dose of 10<sup>6</sup> CFU/mouse. At the same time, when the larvae were infected with two morphotypes, no difference in pathogenicity was observed. Other clinical isolates of the Enterobacteriacea family caused no disease in white mice even at an infection dose of 10<sup>6</sup> CFU/mouse. However,<italic> </italic><italic>E</italic><italic>. </italic><italic>coli</italic> and<italic> </italic><italic>E</italic><italic>. </italic><italic>kobei</italic> caused the lethal process in (90%) in<italic> </italic><italic>G</italic><italic>. </italic><italic>mellonella</italic> larvae. The exception was<italic> </italic><italic>E</italic><italic>. </italic><italic>cloacae</italic>, which caused death in as few as 10% of individuals. In contrast to white mice, 100% of larvae died upon infection with <italic>Stenotrophomonas</italic><italic> </italic><italic>maltophilia</italic><italic>, </italic><italic>Chryseobacterium</italic><italic> </italic><italic>gleum</italic><italic>, </italic><italic>Rhizobium</italic><italic> </italic><italic>radiobacter</italic><italic>,</italic> and <italic>Pantoea</italic><italic> </italic><italic>agglomerans</italic>. The virulence study of different staphylococcal species showed that<italic> </italic><italic>S</italic><italic>. </italic><italic>aureus</italic> and<italic> </italic><italic>S</italic><italic>. </italic><italic>haemolyticus</italic> had a high pathogenic potential for larvae, whereas<italic> </italic><italic>S</italic><italic>. </italic><italic>epidermidis</italic> and<italic> </italic><italic>S</italic><italic>. </italic><italic>saprophyticus</italic> were characterized by significantly lower potential to cause infection. In the surrogate model, clinical isolates of various fungal species:<italic> </italic><italic>C</italic><italic>. </italic><italic>albicans</italic>,<italic> </italic><italic>C</italic><italic>. </italic><italic>tropicalis</italic>, and<italic> </italic><italic>G</italic><italic>. </italic><italic>capitatum</italic> — were most pathogenic for larvae, whereas<italic> </italic><italic>C</italic><italic>. </italic><italic>glabrata</italic> and<italic> </italic><italic>C</italic><italic>. </italic><italic>krusei</italic>, known as most invasive species, caused the delayed death of several individuals. Thus, the pathogenicity study of various microbial species requires to choose most appropriate biological model.</p></abstract><trans-abstract xml:lang="ru"><p>В последние годы представляет интерес поиск альтернативных, так называемых суррогатных, моделей для изучения биологических свойств различных микроорганизмов. Целью настоящей работы была оценка применения личинок <italic>Galleria</italic><italic> </italic><italic>mellonella</italic> для определения патогенного потенциала возбудителей внебольничных пневмоний по сравнению с моделью лабораторных животных (белые мыши). Все исследованные штаммы были выделены из мокроты больных на базе ФКУЗ Ростовский-на-Дону противочумный институт Роспотребнадзора и идентифицированы методом времяпролетной масс-спектрометрии. Вирулентность штаммов оценивали при экспериментальной инфекции белых мышей и личинок<italic> </italic><italic>G</italic><italic>. </italic><italic>mellonella</italic> при заражении различными концентрациями микробов (КОЕ/мл). Как установлено, гипермукоидный вариант клебсиелл вызывал гибель белых мышей в дозе ≤ 10<sup>3</sup> КОЕ/мышь, тогда как классический морфотип был апатогенным даже в дозе 10<sup>6</sup> КОЕ/мышь. В то же время при инфицировании личинок двумя морфотипами достоверной разницы в патогенности исследуемых морфотипов выявить не удалось. Клинические изоляты семейства <italic>Enterobacteriacea</italic> не вызывали заболевания у белых мышей даже при дозе заражения 10<sup>6</sup> КОЕ/мышь. При этом<italic> </italic><italic>E</italic><italic>. </italic><italic>coli</italic> и<italic> </italic><italic>E</italic><italic>. </italic><italic>kobei</italic> обусловливали летальный процесс у (90%)<italic> </italic><italic>G</italic><italic>. </italic><italic>mellonella</italic>. Исключение составил<italic> </italic><italic>E</italic><italic>. </italic><italic>cloacae</italic>, который вызывал гибель лишь у 10% особей. В отличие от модели белых мышей такие редко изолируемые условно-патогенные бактерии, как <italic>Stenotrophomonas</italic><italic> </italic><italic>maltophilia</italic><italic>, </italic><italic>Chryseobacterium</italic><italic> </italic><italic>gleum</italic><italic>, </italic><italic>Rhizobium</italic><italic> </italic><italic>radiobacter</italic><italic>, </italic><italic>Pantoea</italic><italic> </italic><italic>agglomerans</italic><italic>,</italic> вызывали 100% гибель личинок. Изучение вирулентности разных видов стафилококков показало, что<italic> </italic><italic>S</italic><italic>. </italic><italic>aureus</italic> и<italic> </italic><italic>S</italic><italic>. </italic><italic>haemolyticus</italic> обладали высоким патогенным потенциалом для личинок, тогда как<italic> </italic><italic>S</italic><italic>. </italic><italic>epidermidis</italic> и<italic> </italic><italic>S</italic><italic>. </italic><italic>saprophyticus</italic> характеризовались достоверно меньшей способностью вызывать инфекцию. При использовании суррогатной модели на клинических изолятах различных видов грибов обнаружено, что наибольшей патогенностью для личинок характеризовались<italic> </italic><italic>C</italic><italic>. </italic><italic>albicans</italic>,<italic> </italic><italic>C</italic><italic>. </italic><italic>tropicalis</italic> и<italic> </italic><italic>G</italic><italic>. </italic><italic>capitatum</italic>, а<italic> </italic><italic>C</italic><italic>. </italic><italic>glabrata</italic> и<italic> </italic><italic>C</italic><italic>. </italic><italic>krusei</italic>, рассматриваемые как более инвазивные виды, вызывали лишь частичную гибель группы особей в отдаленные сроки. Таким образом, изучение патогенности различных видов микроорганизмов требует подбора наиболее адекватной биологической модели.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Galleria mellonella</kwd><kwd>Klebsiella pneumoniae</kwd><kwd>Staphylococcus spp.</kwd><kwd>yeast</kwd><kwd>yeast-like fungi</kwd><kwd>pathogenicity</kwd><kwd>biomodels</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Galleria mellonella</kwd><kwd>Klebsiella pneumoniae</kwd><kwd>Staphylococcus spp.</kwd><kwd>дрожжи</kwd><kwd>дрожжеподобные грибы</kwd><kwd>патогенность</kwd><kwd>биомодели</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Анисимова А.С., Полеева М.В., Аронова Н.В., Цимбалистова М.В., Павлович Н.В. Oсобенности идентификации грибов рода Candida с помощью масс-спектрометрического анализа (MALDI-ToF MS) // Клиническая лабораторная диагностика. 2022. Т. 67, № 4. С. 244–249. [Anisimova A.S., Poleeva M.V., Aronova N.V., Tsimbalistova M.V., Pavlovich N.V. Pecularities of Candida yeast identification by mass spectrometric analysis (MALDI-ToF MS). Klinicheskaya Laboratornaya Diagnostika = Russian Clinical Laboratory Diagnostics, 2022, vol. 67, no. 4, pp. 244–249 (In Russ.)] doi: 10.51620/0869-2084-2022-67-4-244-249</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Анисимова А.С., Павлович Н.В., Аронова Н.В., Цимбалистова М.В., Гудуева Е.Н., Пасюкова Н.И., Теплякова Е.Д., Носков А.К. Биологические свойства и антибиотикорезистентность Klebsiella pneumoniae и ее роль в этиологической структуре возбудителей внебольничных пневмоний // Антибиотики и химиотерапия. 2023. Т. 68, № 5–6. С. 11–18. [Anisimova A.S., Pavlovich N.V., Aronova N.V., Tsimbalistova M.V., Gudueva E.N., Pasyukova N.I., Teplyakova E.D., Noskov A.K. Biological properties and antibiotic resistance of Klebsiella pneumonia and its role in the etiological structure of community-acquired pneumonia pathogens. Antibiotiki i khimioterapiya = Antibiotics and Chemotherapy, 2023, vol. 68 (5–6), pp. 11–18. (In Russ.)] doi: 10.37489/0235-2990-2023-68-5-6-11-18</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Аронова Н.В., Павлович Н.В., Цимбалистова М.В., Полеева М.В., Анисимова А.С., Водопьянов С.О., Носков А.К. Видовое разнообразие и маркеры резистентности дрожжей рода Candida у коронапозитивных и коронанегативных больных с внебольничными пневмониями // Антибиотики и химиотерапия. 2021. Т. 66, № 7–8. С. 38–44. [Aronova N.V., Pavlovich N.V., Tsymbalistova M.V., Poleeva M.V., Anisimova A.S., Vodopyanov S.O., Noskov A.K. Species diversity and resistance markers of candida yeasts in COVID positive and COVID negative patients with community-acquired pneumonia. Antibiotiki i khimioterapiya = Antibiotics and Chemotherapy, 2021, vol. 66, no. 7–8, pp. 38–44. (In Russ.)] doi: 10.37489/0235-2990- 2021-66-7-8-38-44</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Гланц С. Медико-биологическая статистика: пер. с англ. М.: Практика, 1999. 459 с. [Glants S. Biomedical statistics. Moscow: Practice, 1999. 459 p. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Лабораторная диагностика внебольничных пневмоний: Методические указания МУК 4.2.3115-13. М., 2013. [Laboratory diagnostics of community-acquired pneumonia: Guidelines MUK 4.2.3115-13. Moscow, 2013. (In Russ.)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Лабораторная диагностика внебольничной пневмонии пневмококковой этиологии: методические рекомендации. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2017. 64 с. [Laboratory diagnosis of community-acquired pneumonia of pneumococcal etiology. Methodical recommendations Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2017. 64 p. (In Russ.)] URL: https://www.rospotrebnadzor. ru/documents/details.php?ELEMENT_ID=9036</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Патогенность // Большая российская энциклопедия. [Pathogenicity. The Great Russian Encyclopedia. (In Russ.)] URL: https://bigenc.ru/c/patogennost-b0e100</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Салмова Ю.В., Никифорова Л.Р., Боровкова К.Е. Разработка модели бактериальной инфекции личинок Galleria mellonella (большая восковая моль // Лабораторные животные для научных исследований. 2022. Т. 3. С. 40–49. [Salmova J.V., Nikiforova L.R., Borovkova К.E. Development of a bacterial infection model of Galleria mellonella larvae (greater wax moth). Laboratornye zhivotnye dlya nauchnykh issledovanii = Laboratory Animals for Science, 2022, vol. 3, pp. 40–49. (In Russ.)] doi: 10.57034/2618723X-2022-03-05</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Akinkunmi E.O., Adeyemi O.I., Igbeneghu O.A., Olaniyan E.O., Omonisi A.E., Lamikanra A. The pathogenicity of Staphylococcus epidermidis on the intestinal organs of rats and mice: an experimental investigation. BMC Gastroenterol., 2014, vol. 14: 126. doi: 10.1186/1471-230X-14-126</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Baumans V. Science-based assessment of animal welfare: laboratory animals. Rev. Sci. Tech., 2005, vol. 24, no. 2, pp. 503–513.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Champion O.L., Wagley S., Titball R.W. Galleria mellonella as a model host for microbiological and toxin research. Virulence, 2016, vol. 7, no. 7, pp. 840–845. doi: 10.1080/21505594.2016.1203486</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Curtis A., Binder U., Kavanagh K. Galleria mellonella larvae as a model for investigating fungal-host interactions. Front. Fungal. Biol., 2022, vol. 3: 893494. doi: 10.3389/ffunb.2022.893494</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Cutuli M.A., Petronio P.G., Vergalito F., Magnifico I., Pietrangelo L., Venditti N., Di Marco R. Galleria mellonella as a consolidated in vivo model hosts: new developments in antibacterial strategies and novel drug testing. Virulence, 2019, vol. 10, no. 1, pp. 527–541. doi: 10.1080/21505594.2019.1621649</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Eisemann C.H., Jorgensen W.K., Merritt D.J., Rice M.J., Cribb B.W., Webb P.D., Zalucki M.P. Do insects feel pain? A biological view. Experientia, 1984, vol. 40, pp. 164–167. doi: 10.1007/BF01963580</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>García-Lara J., Needham A.J., Foster S.J. Invertebrates as animal models for Staphylococcus aureus pathogenesis: a window into host–pathogen interaction. FEMS. Immunol. Med. Microbiol., 2005, vol. 43, no. 3, pp. 311–323. doi: 10.1016/j.femsim.2004.11.003</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Giammarino A., Bellucci N., Angiolella L. Galleria mellonella as a model for the study of fungal pathogens: advantages and disadvantages. Pathogens, 2024, vol. 13, no. 3: 233. doi: 10.3390/pathogens13030233</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Gunn B.A. Comparative virulence of human isolates of coagulase-negative staphylococci tested in an infant mouse weight retardation model. J. Clin. Microbiol., 1989, vol. 27, no. 3, pp. 507–511. doi: 10.1128/jcm.27.3.507-511.1989</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Hassan Y., Chew S.Y., Than L.T.L. Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival. J. Fungi (Basel), 2021, vol. 7, no. 8: 667. doi: 10.3390/jof7080667</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Jamiu A.T., Albertyn J., Sebolai O.M., Pohl C.H. Update on Candida krusei, a potential multidrug-resistant pathogen. Med. Mycol., 2021, vol. 59, no. 1, pp. 14–30. doi: 10.1093/mmy/myaa031</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kavanagh K., Sheehan G. The use of Galleria mellonella larvae to identify novel antimicrobial agents against fungal species of medical interest. J. Fungi (Basel), 2018, vol. 4, no. 3: 113. doi: 10.3390/jof4030113</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lemaitre B., Hoffmann J. The host defense of Drosophila melanogaster. Annu. Rev. Immunol., 2007, vol. 25, pp. 697–743. doi: 10.1146/annurev.immunol.25.022106.141615</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Liang H., Wang Y., Liu F., Duan G., Long J., Jin Y., Chen S., Yang H. The application of rat models in Staphylococcus aureus infections. Pathogens, 2024, vol. 13, no. 6: 434. doi: 10.3390/pathogens13060434</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Mai D., Wu A., Li R., Cai D., Tong H., Wang N., Tan J. Identification of hypervirulent Klebsiella pneumoniae based on biomarkers and Galleria mellonella infection model. BMC Microbiol., 2023, vol. 23, no. 1: 369. doi: 10.1186/s12866-023-03124-0</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Ménard G., Rouillon A., Cattoir V., Donnio P.Y. Galleria mellonella as a suitable model of bacterial infection: past, present and future. Front. Cell. Infect. Microbiol., 2021, no. 11: 782733. doi: 10.3389/fcimb.2021.782733</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Nathan S. New to Galleria Mellonella. Virulence, 2014, vol. 5, no. 3, pp. 371–374. doi: 10.4161/viru.28338</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Pereira T.C., de Barros P.P., Fugisaki L.R.O., Rossoni R.D., Ribeiro F.C., de Menezes R.T., Junqueira J.C., Scorzoni L. Recent advances in the use of Galleria mellonella model to study immune responses against human pathogens. J. Fungi (Basel), 2018, vol. 4, no. 4: 128. doi: 10.3390/jof4040128</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Pereira M.F., Rossi C.C., da Silva G.C., Rosa J.N., Bazzolli D.M.S. Galleria mellonella as an infection model: an in-depth look at why it works and practical considerations for successful application. Pathog. Dis., 2020, vol. 78, no. 8: ftaa056. doi: 10.1093/femspd/ftaa056</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Qin M., Chen P., Deng B., He R., Wu Y., Yang Y., Deng W., Ding X., Yang F., Xie C., Yang Y., Tian G.B. The emergence of a multidrug-resistant and pathogenic ST42 lineage of Staphylococcus haemolyticus from a hospital in China. Microbiol. Spectr., 2022, vol. 10, no. 3: e0234221. doi: 10.1128/spectrum.02342-21</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Richmond J. The 3Rs — Past, Present and Future. Scand. J. Lab. Anim. Sci., 2000, vol. 27, no. 2, pp. 84–92. doi: 10.23675/sjlas.v27i2.19</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Russell W.M.S., Burch R.L., Hume C.W. The principles of humane experimental technique. London: Methuen, 1959, 238 p.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Russo T.A., MacDonald U. The Galleria mellonella infection model does not accurately differentiate between hypervirulent and classical Klebsiella pneumoniae. mSphere, 2020, vol. 5, no. 1: e00850-19. doi: 10.1128/mSphere.00850-19</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Serrano I., Verdial C., Tavares L., Oliveira M. The virtuous Galleria mellonella model for scientific experimentation. Antibiotics (Basel), 2023, vol. 12, no. 3: 505. doi: 10.3390/antibiotics12030505</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Sheehan G., Garvey A., Croke M., Kavanagh K. Innate humoral immune defences in mammals and insects: The same, with differences? Virulence, 2018, vol. 9, no. 1, pp. 1625–1639. doi: 10.1080/21505594.2018.1526531</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Tannenbaum J., Bennett B.T. Russell and Burch’s 3Rs then and now: the need for clarity in definition and purpose. J. Am. Assoc. Lab. Anim. Sci., 2015, vol. 54, no. 2, pp. 120–132.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Tsai C.J.-Y., Loh J.M.S., Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence, 2016, vol. 7, no. 3, pp. 214–229. doi: 10.1080/21505594.2015.1135289</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Wojda I., Staniec B., Sułek M., Kordaczuk J. The greater wax moth Galleria mellonella: biology and use in immune studies. Pathog. Dis., 2020, vol. 78, no. 9: ftaa057. doi: 10.1093/femspd/ftaa057</mixed-citation></ref></ref-list></back></article>
